翰森制药(03692)授出856.1万份受限制股份单位

智通财经
28 Apr

智通财经APP讯,翰森制药(03692)发布公告,于2025年4月28日,根据公司于2019年5月27日采纳的首次公开发售后受限制股份单位计划,向776名受限制股份单位承授人授出合共代表856.1万股股份的受限制股份单位,但须经承授人接纳作实。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10